<ul><li>Health-tech firm Medibuddy is looking to raise $130 million in a pre-IPO round, with Avendus Capital as an adviser.</li><li>Founded by IIT Madras alumni, its shareholders include a Liechtenstein royal family fund and Quadria Capital.</li><li>Contrary to reports, Medibuddy clarified that the pre-IPO round target is $60 million, not $130 million.</li><li>The company stated that it is focused on building a profitable healthcare market leader and is not in a hurry for an IPO.</li></ul>

Medibuddy eyes $130 million in pre-IPO

Discover more